1. Home
  2. PEN vs CRS Comparison

PEN vs CRS Comparison

Compare PEN & CRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PEN
  • CRS
  • Stock Information
  • Founded
  • PEN 2004
  • CRS 1910
  • Country
  • PEN United States
  • CRS United States
  • Employees
  • PEN N/A
  • CRS N/A
  • Industry
  • PEN Medical/Dental Instruments
  • CRS Steel/Iron Ore
  • Sector
  • PEN Health Care
  • CRS Industrials
  • Exchange
  • PEN Nasdaq
  • CRS Nasdaq
  • Market Cap
  • PEN 10.5B
  • CRS 9.4B
  • IPO Year
  • PEN 2015
  • CRS N/A
  • Fundamental
  • Price
  • PEN $277.35
  • CRS $170.21
  • Analyst Decision
  • PEN Strong Buy
  • CRS Buy
  • Analyst Count
  • PEN 16
  • CRS 6
  • Target Price
  • PEN $290.93
  • CRS $156.33
  • AVG Volume (30 Days)
  • PEN 451.5K
  • CRS 846.0K
  • Earning Date
  • PEN 04-23-2025
  • CRS 04-24-2025
  • Dividend Yield
  • PEN N/A
  • CRS 0.47%
  • EPS Growth
  • PEN N/A
  • CRS 84.03
  • EPS
  • PEN 0.36
  • CRS 5.30
  • Revenue
  • PEN $1,194,615,000.00
  • CRS $2,878,100,000.00
  • Revenue This Year
  • PEN $14.26
  • CRS $7.55
  • Revenue Next Year
  • PEN $14.21
  • CRS $8.49
  • P/E Ratio
  • PEN $762.38
  • CRS $32.12
  • Revenue Growth
  • PEN 12.86
  • CRS 5.64
  • 52 Week Low
  • PEN $148.00
  • CRS $74.21
  • 52 Week High
  • PEN $310.00
  • CRS $213.66
  • Technical
  • Relative Strength Index (RSI)
  • PEN 53.70
  • CRS 45.60
  • Support Level
  • PEN $253.27
  • CRS $168.84
  • Resistance Level
  • PEN $278.39
  • CRS $179.49
  • Average True Range (ATR)
  • PEN 14.09
  • CRS 12.49
  • MACD
  • PEN 0.97
  • CRS 0.77
  • Stochastic Oscillator
  • PEN 90.04
  • CRS 63.28

About PEN Penumbra Inc.

Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are sold to hospitals and are developed for use by specialist physicians. Within the neurovascular business, the firm offers products for neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. It operates as one reportable segment and its business activity consists of the design, development, manufacturing and marketing of inventive medical products.

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

Share on Social Networks: